the j&j vaccine.hat headline just coming across the bloomberg. the cdc and fda confirming a recommending pause in the j&j vaccine. that is the headline that just crosses the bloomberg. the cdc and the fda confirming recommending a pause in the use of the j&j vaccine. tom: yields don't move all that much. it is very much in equity bloom off the rose. what is important to me is the world cases -- is the word cases. there's obviously multiple involved here. lisa: the question i have from a market perspective is the tail risks that are priced into the market. to so many people have moved past covid. if you look at the survey from bank of america, 15% said covid was not the main tail risk. the pandemic is still here. if we get this news, how disruptive could it be? jonathan: getting some more headlines from the cdc, over 6.8 million doses of j&j have been administered in the united states. j&j stuck in the premarket down by about 2.6%. there it is, the cdc and fda confirming recommending a pause in the use

j&j or not >> absolutely, carl.tement that none of these very rare events have been observed with the mrna vaccines from pfizer and moderna. those have been administered in larger quantities here in the united states. and so what we are hearing from a lot of states is they're taking the recommendations from the cdc and fda and rescheduling folks for scheduled for the j&j for the pfizer or moderna vaccines hearing from this, they're acknowledging people might be worried if they got the vaccine within the last few weeks. saying if you got it a month ago, there is absolutely no reason or very little reason to be concerned about this. and noting what people should look out for even though this is extremely rare if they've been vaccinated with j&j vaccine in the last three weeks or so. i'll continue to listen to this and hear what the questions yield and we're certain to hear more from the government throughout the course of the day. we'll bring all that to you. >> and we look forward to hearing more from you, meg thanks

j&j stockdale down -- j&j stock still down. what it means for j&j.is bloomberg. ♪ so you're a small business, or a big one. you were thriving, but then... oh. ah. okay. plan, pivot. how do you bounce back? you don't, you bounce forward, with serious and reliable internet. powered by the largest gig speed network in america. but is it secure? sure it's secure. and even if the power goes down, your connection doesn't. so how do i do this? you don't do this. we do this, together. bounce forward, with comcast business. ingand while her friends are doing the heavy lifting, jess is busy moving her xfinity internet and tv services. it only takes about a minute. wait, a minute? but what have you been doing for the last two hours? ...delegating? oh, good one. move your xfinity services without breaking a sweat. xfinity makes moving easy. go online to transfer your services in about a minute. get started today. ♪ alix: live from new york, i'm alix steel. guy johnson is off today. we are counting you down to the rp impose on "bloomberg markets ." here's everyth

j. but we have to take into account we're comfortable accepting more complications in cases than what i call a little bit of knee-jerk decisions of not getting the fda and cdc a chance to review it. >> how long -- of all weeks to have a pause in j&j, this actually wasn't a bad week. they had a -- this was a low inventory week for j&j. we had the manufacturing problem. they're a couple weeks behind getting back ramped up. but there's going to be some of the vaccine that was scheduled to be injected into arms won't be. is there an expiration date? how much vaccine are we losing here potentially? >> i don't think -- we should not be losing -- we shouldn't have vaccine -- remember, the nice thing about j&j is it had a much longer shelf life, not just in refrigerators but even out of the refrigerators so i don't think we're going to be throwing doses away, because i do think we will come to some -- will come to some message around these safety signals soon. but i do think the manufacturing is

j?phase 3 data were presented to fda, they were made available to the american people this is a transparent process. this was based on studies of 30,000 to 40,000 individuals the safety signal for the j&j vaccine did not manifest in that group. it only came to light once the vaccine was given to millions. that tells you how rare this clotting event is. but now that it's detected, it's a statistical thing. we know if we see an uptick in association with j&j, if the recipients of the j&j vaccine had a higher frequency of clotting than expected in the background population frequency, then it's a statistical argument. >> so if there is a link, if this edo find a link between the two, then what will they withdraw the vaccine >> not necessarily they may try to see if it's -- for example, and i've only seen preliminary news reports if it was true it was only in women, younger women, maybe people with certain background conditions, they have to examine the medical charts they'll have to see if t

do those kind of coexist with the j&j, or does j&j increasingly become more of a med tech company?att: j&j has a lot going on in pharma besides vaccines. they have a huge oncology program, immunology business, and all of those businesses are doing, really operating at the top of the industry. so like any other drug, whether for cancer or anything, think these vaccines will have to compete in the world of long-term results and adverse events, and regulators in the market will decide which ones will dominate and be preferred over time. i think that is the way this is going to work out. all of this is super new because this was developed fast, so it is early to say. we will learn more about that in the next year or two. guy: we are trading $164 now. the high was $170 over the last year. what gets this stock to your price target? matt: great question. to the extent that there is a recovery trade underway and investors are rotating into names both inside and outside of health care that are exposed to a bounce back, and utilization and consumer activity, j&j in that environment is never

j pause, particularly given more of those doses will be giving up to adults to make up the j&j doses? is there a procurement provide ses under way for that? -- process under way for that? and if the johnson & johnson is paused -- project out some estimate of what's -- what the impact will be in terms of adults being vaccinated? jeff: so zeke, on pfizer and moderna, you'll recall in february the president ordered 100 million additional doses of each pfizer and moderna, which brings us to 600 million doses by the end of july. the pfizer c.e.o. announced that he's accelerating that time frame to mid-july. that's enough doses to vaccinate 300 million americans. so there's no further procurement underway in the moment. so there's plenty of pfizer and moderna doses on order and being delivered. furthermore, we're doing everything we can to accelerate the delivery of those doses. and, again, pfizer announced they'll deliver their first 200 million of their 300 before their may 31 deadline and we're working with moderna to do everything to accelerate those doses. i forgot. can you repeat your

governor newsome also receiving the j&j vaccine. in fact, he was very happy and chose this brand because of the single dose. now, here are the symptoms to look out for. >> so, this is a really rare and specific kind of clot that happens in the brain, to be watching a new headache that's not your usual. number two, blurry vision. and, you know, anything after that i think you would normally go to the doctor anyway or the emergency room. so loss of consciousness, seizures, and those kinds of symptoms. the more common kinds of clots would be leg pain, calf pain and shortness of breath. >> headaches, blurry vision, and leg pain among the most common things seen here. again, the fda says it's very rare that you're going to get a blood clot from receiving that j&j vaccine. however, the catch-22 here, did the fda overreact? dr. chin hong says no, the fda did not overreact, but there is a possibility that some people, maybe many people that were on the fence about getting any of the three vaccines will now choose against getting vaccinated.

j vaccine? dr. fauci: the question you are asking gets back to several of the questions here. that is the reason why the cdc and the fda want to take a look at this and say, are there some categories now where people outside of the category down have any of the factors so it would be ok to go on? it is entirely conceivable, making new predictions, that there may be some restrictions. we don't know that now. that is the reason why they are working very hard to answer the question you are asking. reporter: what is your medical advice for people who have recently received the j&j vaccine? and may be concerned about this? dr. fauci: if someone recently within days, i would tell them to first of all, don't get an anxiety reaction because remember, it is less than one in a million. however, having said that,. pay attention. . . do you have symptoms? headache, shortness of breath, chest discomfort, do you have anything that resembles a neurological syndrome? obviously, if you have something as serious

j&j move higher. jim >> i think the j&j because of the problems we merging bio isn't nearly as big a deal obviously a big deal for people who have taken it. not nearly as big a deal for the coming months because j&j was already in the p.enalty box i this moderna and pfizer continue the moment. and i'm not concerned about the reopening of america maybe there will be a halt in vaccine, we had what, 3.2 he va they can get it. and they are happy with the pfizer moderna second day, people are a little nauseous. obviously j&j now paused but i don't think this is going to really impact the market nearly as much as it indicated >> with bill dem czech from pnc who was saying he thinks the economy is firing on all cylinders and maybe this impacts the margin in terms hoff quick the vaccine get out but maybe only by a couple weeks >> obviously j&j was already just a trickle i think what people are getting are pfizer and moderna those two companies are on their game i don't expect this to impact travel and leisure

j shot. one shot, easier in that regard. it doesn't need to be stored in same temperatures as others so it is easier to distribute, neil. neil: all right. jackie deangelis, thank you very much. i want to go to my friend bob la him at the st. joseph's institute of health. six people developed them out of nearly seven million who have gotten the vaccine. is that a overreaction how would you describe it? >> it is one in a million, neil, and that is very, very rare. we saw this with the astrazeneca vaccine in europe as well. this is an autoimmune finding. remember these vaccines are viral vector vaccines which means it is uses a virus fairly innocuous to carry the antigen or foreign virus particles into your body. apparently the clues here, are women really develop this more than men and secondly, that there appears to be a substance on the platelet, the platelet is involved in clotting of your blood, a substance own your platelet which an antibody develops and the antibody causes the loss of tho

the way j and j traded today was very good in earnings. it's a big story, worth talking about, they did erving right in terms of what j and j did in terms of what the vix and broader market did illustrates that. >> specifically in your tweet, grasso, you said continue to buy the weakness in iwm, small caps. >> right, right. and for me, that's the reopening trade. and the overall market i think to guy's point, we don't want to belittle the issue going on with the six people, but there's more than enough vaccine out there from pfizer or moderna and when you look at the iwm that's been in the center of the reopening trade, it's been the center of rising rates, everyone rushed for safety so rates came in just a touch. so i thought that would be more of a buying opportunity for the iwm going forward. >> that allowed the tech trade to go higher jeff mills, how do you interpret all these cross currents today >> well, just about rates and tech, we talked about this late last week but that's been my thesis for the past couple weeks. i think we cont

& j?k about 650 different variants of the most important part of the spike protein. those are going to continue to grow. the virus mutates and the current vaccines they almost all work pretty well against the variant. az has had a problem against the south african strain but even for the strains that mutate these vaccines will continue to provide protection. that said, moderna and pfizer are both anticipating creating modified booster shots, to what we do with influenza. overtime, that will be necessary we'll need to modify our vaccine s but the vaccines, they elicit antibodies and t-cells and both work on many different places on the virus so even though you have a little bit of reduction of efficacy those vaccines should provide us a good amount of protection and now we're better-positioned to adapt them in the future as the variants do arise. ashley: but does that prediction wear off and do we know if perhaps beyond six months we start to drop-off and we really need that booster shot, o

and one way or the other, they'll make a decision about j & j. don't know what that is going to be. but thinking about what the possibilities are, one of the possibilities would be to bring them back, but to do it with some form of restriction. or some form of warning. but i believe by friday we're going to know the answer to that. >> brennan: you told cbs this week that one of the things you think needs to be investigated is the role of hormones here. looking at the fact these women are child-bearing age, you wanted to look whether they were on birth control. does that indicate that the restrictions could be gender-based? becawe now have only seen six peohanism and what we've seen with a.z., astrazeneca, in the european union and the u.k., has the same sort of thrombotic theme, namely a clot, and it's a very unusual situation to see that. and yet in those circumstances, where they've seen many more with that different vaccine, it has not only been restricted to women. and that's one of the points that we want to be careful about. you don't want

j. it was a very small percentage of all the vaccines being done. moderna and pfizer are being used in much higher numbers. moderna and pfizer do not have this blood clot concern. the thinking is that we can reach the goals that we need to reach in the united states without using johnson & johnson jim. >> j&j doses about 3% of the total number of vaccines administered so far. elizabeth cohen, thank you so much. >>> let's go to one of the sites where johnson & johnson vaccines were expected to be administered. we're at the center in new york, a major vaccination site. i got mine there. it was pfizer. what is the latest there? is j&j a big part of new york's plan? >> yeah, well if you remember, jim, j&j helped make the afsent near a 24-hour vaccination. it wasn't a huge part of the distribution process but added to it. there were disappointment from people we spoke to this morning that were arriving -- >> hold that thought if i can. hold your thought if you can, we're going to go right to

j and the fda. i do think that the company is doing everything they can. as we talked about, they now have complete responsibility for that whole facility. they have their best people at that plant. they are partnering with merck, who has expertise, and we are optimistic that once they have the fda authorization, they will be able to deliver, as they told us, at that 8 million per week cadence. i do want to remind everyone we have had 90 million doses delivered across the last three weeks, and that we more than tripled the production of doses and the delivery of doses. under this principle, once a dose is available, we deliver it right away, across the 11 weeks or so we have been in office. dr. murphy: jeff, may i add one thing to caitlin's question about the vaccine efficacy? to build on what tony said, we still have high confidence the vaccines are effective, but because it is not perfect, that is precisely why we are urging people to be cautious, why we have such an emphasis on getting the overal

and j vaccine? >> the question gets back to several of the questions here. that's the reason why the cdc and fda want to take a look at this and say are there some categories now where people outside of that category don't have any of the factors so it will be okay to go on. it's entirely conceivable there may be some restriction in an age group or not we don't know that now that's the reason why they are working very hard to answer the question you're asking >> what's your medical advice for people who received the j and j vaccine and may be concerned about blood clots. >> if someone recently, within days, i would say don't get an anxiety reaction because it's less than one in a million however, having said that, pay attention. do you have symptoms headache you have shortness of breath, chest discomfort do you have anything that vemv resembles neurological procedures the sinus thrombosis is the draining of the blood in the p brain and it will cause enough symptoms to make you notice it >> they had

j. when you get out into the real world, you're giving it to tens and tens of millions of people, and it is at that point that you see if there is a rare adverse event. you will pick it up as you get into the millions of people who are vaccinated >> what would you recommend to anyone who has had the j&j vaccine in the last couple of weeks? is there anything they can do >> well, right now i would make sure they understand that this is really a very rare event. and, in fact, it had occurred in people in a very small bracket of time frame, between 6 and 13 days so if you have received a vaccine a couple of months ago, then i would think you would have absolutely nothing to worry about. i would be surprised if there was any issue there. if you had received it within a period of, let's say, two or three weeks or a week or two, i would tell them, a, again, it's a very rare event. but you should be alert to see if you get symptoms of a severe headache or some issue with movement, stroke-like sy

& j site.t cociunl officis alsaid they were abltoe change to pfizer this rnmoing saying th eywould not expe ctancay ncellatis.on >>reporter: they're also working to make su rethe anch ge don'est disrt uptheir vaccinioatn goals theier. >> wree' certain lyswitchg in out all ofhe t johnson & hnson vaincce making the prop aerrrange ments to make sure any dose we vegi be it modea rnor pfizer will followedy ba. >>> oppele who wo rkin santa clara that are 16 years of m ai anold der to sign up for an pointmen t. atim te we're hearg innccoerns aboutht e supplyth at's t nothe seca in the bay area's most pulous uncoty. the county system is cereiving a t loof vaccines, significanint crea sein vaincce ppsuly that 'scoming redictly fr tomhe federal vegornment. combin edwith the increase from our stat e,we now ha veenghou ccvaine real lyto quicy klreach our goal of protecting our enreti community. >>ep rteorr: san anfrcisco also annoceund today it would be openg inup vaccinations to everyone. however the city

so whatsh ould u yodo to soonmee o'whs already gone the j&j vaincce? know soonmee reh acout tome thisor mning and said, oh my gosh, i got a few da ysago. th aeyre kind of worried now, what shod ulthey be lookg inout r?fo f>>irst of all, they shouldt n' rry. again, isth is so rare, they wi llprobably not know anyone el sein our cilerc who wi ll havehi ts, if it is absolute links to the vacce,in we are not even sure of that yet. whateo pple shldou be lookg in out for ulwod be sereve headac hethat doesn't go away, that's anew ndki of adheache. blurry visn,io sympto ms stroke, so you can move parts of yr oubody. you may ha veseizures, those arsoe rt of the most serious things tolook out fo r,d ane th last serio usthings, which are also soasciated thwi clotting, that would be pa inin uryo lfca and shorestns of breath, maybe me llbey painbelly painbellpay n soasciated thwi other kinds of clots. >> teinresting. i'm getting a quesonti from faceokbo, jennif eris aski, ng especial lybecause isth has all happen edto mewon, is it because ofbirth control? the dolep

j vaccine? >> the question you're asking gets back to several of the questions here. that's the reason why the cdc and fda want to take a look at this and say, are there some categories now where people outside of that category don't have any other factors so it will be okay to go on? it is entirely conceivable, making no predictions, that there may be some restriction in an age group or not. we don't know that now. that's

j. or how the eu will determine but officials say some sort of vaccine passport will be necessary. a digital document that will show proof of vaccination but just like before that, this issue is at the center of a heated debate. contessa brewer explains >> many cruises may require vaccination. airlines including united are rolling out apps so passengers easily can document if they've had their shots. brown, cornell, rutgers universities intend to require students to be vaccinated to return to campus basketball, the miami heat plan to offer vaccinated only seating sections. >> i think we're going to be very willing to present ourselves in a health security way than we imagined today. >> reporter: health passports may play a big role in las vegas where crowds are crucial to the economy and casinos and conventions, sports or entertainment. >> the ones who fly high -- >> reporter: like cirque du soleil the company's chairman is jim murren >> it's just, in my mind, analogous to 9/11 when post

j vaccine? dr. fauci: the question you're asking gets back to several of the questions here. that's the reason why the cdc and fda want to look at this and say, are there some categories now where people outside of that categories don't have any of the factors so it is ok to go on? it is entirely conceivable there may be some restriction in the age group or not. we don't know that now. that's the reason why they are working hard to answer the question you're asking. reporter: what is your medical advice for people who have recently received the j&j vaccine and may be concerned about blood clots? dr. fauci: if someone recently within days -- i would tell them do not get an anxiety reaction, because remember, it is less than one in a million. however, having said that, pay attention. do you have symptoms? headache, shortness of breath, chest discomfort? do you have anything that resembles a neurological syndrome? obviously if you have something as serious as a seizure, that is pretty clear. but th

j&j obviously dominating headlines today.dc and fda asking sites to temporarily halt usage because of rare occurrences of a blood kloss disorder and names like zoom and peloton moving higher and boeing monthly order numbers crossing the tape. those headlines you will see bottom of your screen. >> meanwhile, carl, heating up to a brand new level grab holding the biggest hide hailing and food delivery company looking to go public, nearly $40 billion the world's largest spac deal ever completed and major milestone for the m & a frenzy that swept financial markets the move also means, guys, that grab's valuation has more than doubled in just 18 months. have a listen to anthony on "squawk box" earlier. >> we are category leader in ride hailing, in food delivery, and in mobile payments, and you're talking about $180 billion addressable market option here. now, when you think about how we have grown, we've really grown and grown sustainably. >> guys, here's how i see it growth, growth everywhere and not a profit to be seen. as antho

again, only six reports with j&j which is extremely bare. in the north bay the "press democrat" reports 39 people who live in sonoma county did contract covid after they were totally vaccinated, a reminder even though pfizer and moderna are 09% effective, they aren't 100% and some people could still contract the virus. dr. anthony fauci said that's not surprising given that tens of millions of people have already received their shots, still your chances of contracting covid after vaccination is very low. reporting live here in pleasanton, bob redell, "today in the bay." >> bob, thank you. >>> 6:07. no movement either forward or backward when it comes to reopening in the bay area following yesterday's guidelines from the state. all bay area county also remain in their current tier status. all bay area counties are currently in the orange with solano county in the more restrictive red tier. across california, three counties are in the yellow tier, 33 in the morning and 21 in the red. merced county is in the most restrictive purple tier. >>> a

j vaccine. this is just audio, and we're going to bring it to you. they are following that recommendation, they're not going to give the j&j vaccine to people for now. they say this is out of an abundance of caution and find out after the precaution. this is after six reported cases of a rare type of blood clot. that is six out of more than seven million people that have gotten it. the safety and well-being of the people who use our products is our number one priority. so let's go to natalie azar. mike memoli, and lara barrett is in michigan. dr. azar, perspective is so critical here. we're talking some -- almost seven million vaccinations administered from johnson and johnson. you have six rare clots that have happened here. balance out what people need to know and the perspective that is important walking into this. >> good morning, hallie. certainly this news is extraordinary. as you point out the thing that i really, really to reinforce to folks is this is extremely rare. what we really want

, gotten the j&j vaccine, making cases of the unusual reaction less than one in a million. still, tonight, the announcement is alarming for those who received the johnson & johnson shot and further stoking fears among those hesitant to vaccinate at all. dr. anthony fauci is joining us to answer your questions in just a moment. but first cbs' jericka duncan is going to lead off our coverage tonight from new york. good evening, jericka. >> reporter: good evening to you, norah. while the occurrence of these blood clots appears to bese blood clots appears to be extr extremely rare, this pause really allows health officials to figure out what happened and also warn doctors about the symptoms. also tonight, we're learning that johnson & johnson will delay its roll-out in europe. tonight, pressing pause, americans are being turned away from the johnson & johnson vaccine, some offered pfizer or moderna instead, after the stunning announcement that six women developed a rare blood clot in the brain after getting the vaccine. >> this is a recommendation, and it's not a mandate. it's

the bay area has decides to stop using the j & j vaccine for now. here's what that means around the area. in contra costa county they are keeping appointments for now. only a small percentage of the vaccines are johnson & johnson there. the mass vaccination site was relying on j & j but but it was able to switch to the pfizer vaccine and did not have to cancel any appointments. in santa clara county, that county does not expect the change to slow down its plan to vaccinate everyone. it too will switch appointments to pfizer and moderna. so it looks like the impact will be minimal here in the bay area for now. >> from a supply chain standpoint, i don't think it will hinder it as much as it could if it was pfizer or moderna. >> reporter: this also won't be a huge problem in san francisco. of the 10,000 doses the city received this week, only 500 were johnson & johnson. across the state, 8800 appointments made through the my turn website are for the j & j vaccine. so they're having to work on whether to cancel or change those. across the state, the sta

and j's shot.ne of them died. officials stressing that thesed a versus events are extremely rare and the pause is out of an abundance of caution. >> 10s and 10s of millions people who received vaccine with no adverse affect. this is a really rare event if you look at what we know so far. they have had 6 out of the 6.85 million doses. which is less than one in a million. >> still health experts say call your doctor if you experience severe headache, abdominal pain, leg pain or shortness of breath within three weeks of vaccination. in a statement, johnson & johnson said is that as of now, no causal relationship exists between be the events and the vaccine. despite the pause, the biden administration said it's still hoping to have vaccine doses available for every american adult by the end of next month. >> we have more than enough supply of pfizer and moderna vaccines to continue the current pace of about 3 million shots per day. >> reassuring comments as dozens of states see cases rising. michigan a

j shot. eight bay area counties and the city of berkeley have released a joint statement, saying the risk of blood clots is low and the j&j vaccine can safely give it again. the federal government pause the use of the j&j vaccine for two weeks, after 15 women reported getting blood clots. 7 million j&j shots have been given. the cdc gave the all clear on writing for the j&j vaccine to be used again. live in san francisco, amy hollyfield, abc7 news. >>> thank you, amy. millions of americans are not getting their second doses of the covid-19 vaccine. the new numbers from the cdc show about 8% of americans have missed the second shot. this is about 5 million people. that is more than double the rate among people who got vaccinated in the first several weeks of the nationwide campaign. the cdc says, their research shows, the reasons varied from people who were afraid of side effects, to some people who feel that they are protected enough after just getting one shot. but that does go against recom

j vaccine?back to several questions here. that's the reason why the cdc and the fda want to take a look at this and say, are there some cat glories now where people outside of that categories don't have any of the factors, so it will be okay to go on, it is entirely conceivable, that there may be some restriction in an age group or not, we don't know that now. that's the reason why they're working very hard to answer the question you're asking. >> what's your medical advice for people who have recently received the

j shot. as far as experts can tell, this is the first male patient anywhere to show symptoms of the rare syndrome after receiving the one-dose shot. but the timing is troubling as it comes as every local county is preparing to put the j&j vaccine back in the rotation. >> you can be on the lookout, but i think they did the right thing, which is to put a warning label on it but not stop the vaccine. >> reporter: prior to this case, every other case has been a woman nearly all between the ages of 18-49. three cases were fatal. while all that may sound scary, they're extremely rare, 16 cases in nearly 8 million doses given. vaccination hesitancy is a real concern but people we've talked to say they still have faith in the j&j one-shot vaccine, including a hayward man who's scheduled to get the shot next week. you're going to get the j&j? >> yeah. >> reporter: you don't have any concerns at all? >> no. >> if i hadn't been vaccinated already, i would get it. >> they've run tests on hundreds of thou

and j vaccine. we will resume the use of the vaccine as early as this weekend." medical doctors say there's still a slight risk within the first two weeks of getting the johnson & johnson vaccine and that one out of 100,000 people per year can still develop blood clots without the vaccine. >> why is really going to be the question that we have to continue to look at. >> reporter: stanford's infectious disease specialist dr. haley ginz sits on the fda's committee that authorized the johnson & johnson vaccine for emergency use. she's concerned the pause will impact vaccine hesitancy among women. >> by providing this vaccine we're saving thousands of lives that would be lost to covid. >> reporter: these two friends are both vaccinated. neither got the johnson & johnson vaccine. so when we asked if they would opt for this option, they had mixed reactions. >> so given a choice i would not prefer it. >> i'd take a one in a 1 million chance of getting a blood clot which i think is something that i can risk

j&j says it is proactively delaying rollout in europe. mandatory tighter restrictions on virus hotspots. the controversial law goes to parliament, putting the now fractious cdu/csu -- the now fractious cdu/csu union and focus. over in europe, you have european stocks up by 0.1 percent, but the real action is in retail, travel and leisure. what i am watching in terms of where the outperformance and reopening is going to be is euro sterling, up by 0.2%. if vaccinations are picking up in europe, mario draghi for example once a production hub in italy to rollout more vaccines, that is going to be good for the economy, so maybe vaccination trade moves from the u.s. to the u.k. and now to europe. we are seeing that play out in the currency markets. we also have a ton of supply coming online in the market. it wasn't met with a lot of fervor when it comes to the bond market. yields pretty much flat on the day. the action in the bond market also over in italy, with yields up by two basis points. sort of the status quo over here in europe. in the u

erin, what is the feeling on j&j? >> reporter: there is demand for j&j.s seen as a critical component of the overall vaccination strategy here at this center in south l.a. this is one of the hardest hit areas of los angeles. at one point it saw that 25% of the people here had been infected by the virus. it's densely populated. many migrant workers live here, many people also living below the poverty line. as you can see behind me, a busy vaccination center just over that way. those are the tents where they're administering the shots. the area right here is called the pit. this is where people go to wait for those potential side effects after receiving a vaccine, and in this tent over here is where they're preparing the actual vaccines. over here you see they just finished up a tray of pfizer. right here is the johnson & johnson shot. everyone who receives one of these shots will also receive this pamphlet warning of those rare side effects you were referring to, katy, and the health director here tells me this is an essential component to their strategy,

j vaccine. they are not sure they won't be around for the second shot. there's transient populations in the country, so there's -- even though if you look at the shots before the pause, j&j was making up 1 out of every 17 doses at ministered. there's certain populations that this would be very beneficial in the united states and around the world because of the not needing the cold storage. it can get into a lot of areas that the mrna vaccines have a harder time address, so it's beneficial for sure. we can vaccinate without it, but it does make it a lot easier. >> and, again, the risks of covid are much worse and greater than the risks of this clotting situation. san >>> today the cdc officially recommended that pregnant women get the coronavirus vaccine. this is after a study found no safety concerns in pregnant women who got the vaccine in the third trimester, no safety concerns for their babies. why is this an important change in the language they are using? >> well, you'll remember in the ori

j covid vaccines. in a joint statement they say the risk of people developing blood clots is extremely low. it is a little unclear when each county will begin using the vaccines again. contra costa county will begin using them tomorrow but san francisco and san mateo counties say t going to wait until some new labels and warnings can be printed before offering the vaccine again. sonoma county was not part of that joint statement that we just mentioned. we've reached out to county health leaders there for more information. this comes as california's positivity rate dips back down to 1.3%, that is the lowest in the country. >>> a live look at the oakland coliseum, where more changes are coming. pedestrian access to the coliseum is now closed. if you're set to get a second dose walk-up appointment during the week of may 2nd you have to use b.a.r.t. and the pedestrian bridge and if you need to get vaccinated, we can help with that. led to our website, click on "how to get acine appointment" in the trending

j now?e i don't have a science degree of any kind, medical or otherwise, but would you cut down on the risk if the j&j dose was split into two and you had sort of -- there was a pause in between the two doses? is it something about it that since it seems to be something that happens within a week of getting it, is it too much of one dose? and if you're j&j, do you look at that as a way of trying to restore some confidence in the vaccine? >> that would be making it up. it's a windows vaccine right now. the biological base problem is the same as the astrazeneca vaccine, which is you make an antibody response by a protein that causes platelets to be activated. we know that. what it would take to decrease that immune response for something that is so rare as to be one in a million, i don't know yet. i don't think we know that yet. until we know more, we can't do that. >> at this point, resolution in less than a week. is that your only hope here? or if this thing drags on, are we going to take a

how's the j&j pause being felt there? >> reporter: even if just for a couple of days, shep, doctors here are really disappointed about this news because michigan is in a very dire situation. they were looking for j&j vaccines to provide a more quick solution because it's a single dose and because its efficacy is only two weeks after you get that dose. so i spoke with a doctor here at beaumont hospital. he's been managing the covid floor for well over a year today's news came with some concern from him. >> the johnson & johnson vaccine was one of the big tools we hade so to have that temporarily off the table is -- it's -- it's pretty discouraging because we really were relying on getting that single dose vaccine out to try to prevent these burgeoning numbers we've got. >> reporter: he expressed the concern about the potential for vaccine hesitancy or the drop in confidence around any vaccine at all. he also noted the reason they're seeing this surge right now in michigan is even though everyone is eligible, people aren't

j safely rolling out. whether that be restricting it to men or developing a preventive strategy for this particular side effect will be critical but we have to keep vaccinating the country. again, this kind of condition is much more common with the virus than the vaccine. we have to protect people. >> dr. david agus, thank you very much. >>> and this morning's announcement caught state health officials off guard and also pushed the biden administration into action. one state official tells cbs news this could add to vaccine hesitancy and make it harder to vaccine the maximum number of adults by the summer. nancy cordes is at the white house for us. nancy, good morning to you. july 4th was the target for some return to normalcy we heard from the white house just a month what are officials saying there now? >> tony, they're saying they're not sure what this means because they don't know how long this pause and use of the j&j vaccine is going to last. this is one of the things that the fda is going to be taki

women between the ages of 18 and 48 who have received the j&j covid vaccine. "the new york times" reports one woman died. another woman hospitalized in critical condition. but i also want to put this in perspective about the numbers here. nearly 7 million people in the united states have received j&j's covid vaccine so far. this is six people. the fda will hold a news conference two hours from now. with us, chief medical correspondent dr. sanjay gupta and dr. paul offit, director -- member of the fda's advisory committee. he was involved in the process of assessing j&j's vaccine. so many questions for you. sanjay, in the simplest terms for everyone watching, especially women between 18 and 48, what does this mean for them? >> i think this is something that's of concern. i mean, it is a rare side effect, but what we are hearing is that, as you mentioned, women between 18 and 48, there was six women who developed a significant blood clot in the veins that drain blood away from the brain. the cerebral sinuses or cerebral veins. we're trying to get an image to sho

is the j&j shot safe and what symptoms to be on the lookout for. the charges and the resignations. tonight, the fallout after daunte wright is shot dead by police. why the police chief just resigned, and could the 26-year veteran who shot wright face imminent charges? breaking news, leaving afghanistan, president biden to announce an end to america's longest war, pulling all u.s. troops out by the 20th anniversary of the september 11th attacks. the chauvin trial, the defense begins its case, but the big question tonight: will the former officer take the stand? lying in honor -- a widow's pain, the emotional tribute to capitol police officer billy evans, what the president told the officer's family. break in the case, a father and son arrested in the disappearance of kristin smart, who went missing a quarter of a century ago. radioactive release inside the japanese plant that dumped contaminated water from the wrecked fukushima nuclear plant into the pacific ocean. an heroic rescue, when a car flipped in a canal, the life- saving decision, with no time to spare. this is the "cbs eve

the j&j shot was easier to take on the road.&j does not need to be stored at cold temperatures like the others. in marin county, they say this will be forcing them to change up their plan to vaccinate the homeless. >> unfortunately now, we are having to shift to pfizer for those mobile operations. we are going to continue that pace but it is going to be with a different product that is just not as easy to work with. >> reporter: the vaccine from j&j makes up only 4% of the state's supply. officials think the impact will be minimal. they are working to conver of the appointments to moderna and pfizer. the governor does not think this will impact the target date of june 15th for reopening the state. live in pleasanton, amy hollyfield, abc7 news. >> thank you. >>> there is a concern about the psychological effect of all of this. the pause of the vaccine has doctors worried it could lead to hesitancy. a doctor was helped lead the effort is concerned because they relied heavily on the single shot. this could be a setback to the trust

. >> reporter: it happened here at a emergent biosolutions in baltimore, 15 million j&j doses ruined after the ingredients for the astrazeneca vaccine were discovered in the batch. the astrazeneca e ingredients produced on the other side of the same facility j&j says its own quality control caught the error and this batch was never advanced to the filling and manufacturing stages of the manufacturing process. none of the u.s. j&j doses are affected. >> johnson & johnson has made clear that they expect to deliver 24 million doses in april and that they expect to meet their commitment of 100 million doses by the end of may >> reporter: we visited the emergent plant in february. for months this pandemic response manufacturing plant in baltimore has been manufacturing vaccine for both astrazeneca and johnson & johnson, awaiting approval. >> in that bag we actually go the cultures that are used to eventually manufacture the vaccine itself. >> reporter: but the fda still has not fully certified emergent's baltimore facility >> their quality systems caught it, as designed and we move forwar

. >>> what to do now with the j&j vaccine? the cdc holds an emergency meeting, the push for more doses of pfizer and moderna. >>> the capitol insurrection, now we know they had the warning, that congress itself was the target so why the directive not to use their strongest tactics against the mob? new details from a scathing watchdog report. >>> plus, bernie madoff dead at 82, the helpers behind the vaccine bots, and how americans are spending their stimulus checks >> announcer: live from cnbc, the facts, the truth, "the news with shepard smith." >>> good evening, the police officer who killed daunte wright is in jail tonight, arrested and charged with second degree manslaughter this is kim potter wearing an orange jumpsuit now instead of a uniform. potter's arrest comes just three days after she shot daunte wright during a traffic stop for expired tags in the minneapolis suburb of brooklyn center. tase him, tase him, tase him i just shot him. >> according to the police chief who has since resigned, potter thought she was firi